We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$9.8B
AUM Growth
-$1.96B
(-17%)
Cap. Flow
-$53.6M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
15.05%
Holding
1,967
New
854
Increased
344
Reduced
350
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$97.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$80.3M |
| 3 |
Teleflex
TFX
|
+$76.7M |
| 4 |
Accenture
ACN
|
+$74.6M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$74.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$140M |
| 2 |
Quest Diagnostics
DGX
|
+$97.7M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$94.3M |
| 4 |
Tractor Supply
TSCO
|
+$78.2M |
| 5 |
AET
Aetna Inc
AET
|
+$77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.48% |
| 2 | Consumer Discretionary | 18.77% |
| 3 | Technology | 12.96% |
| 4 | Financials | 11.62% |
| 5 | Industrials | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Anika Therapeutics
ANIK
$199M
| $4.51M | 0.05% |
+134,333
| New | +$4.85M |
|
|
FSCT
477
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $4.51M | 0.05% |
173,413
-457,750
| -73% | -$12.7M |
|
|
EGRX
478
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $4.49M | 0.05% |
+111,464
| New | +$5.74M |
|
|
EEX
479
DELISTED
Emerald Holding
EEX
| $4.48M | 0.05% |
+363,130
| New | +$4.7M |
|
480
Range Resources
RRC
$9.11B
| $4.44M | 0.05% |
+464,413
| New | +$7.06M |
|
481
Vishay Intertechnology
VSH
$5.86B
| $4.43M | 0.05% |
246,091
-902,573
| -79% | -$17M |
|
482
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
| $4.42M | 0.05% |
51,102
+25,741
| +101% | +$2.33M |
|
|
BMTX
483
DELISTED
BM Technologies, Inc.
BMTX
| $4.37M | 0.04% |
+450,000
| New | +$4.31M |
|
484
Comfort Systems
FIX
$61B
| $4.36M | 0.04% |
+99,703
| New | +$5.1M |
|
|
GB
485
DELISTED
Global Blue Group Holding
GB
| $4.34M | 0.04% |
+450,000
| New | +$4.34M |
|
|
FMBI
486
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $4.33M | 0.04% |
+218,848
| New | +$5.03M |
|
487
CoreCivic
CXW
$3.1B
| $4.32M | 0.04% |
+242,450
| New | +$5.32M |
|
|
SCG
488
DELISTED
Scana
SCG
| $4.31M | 0.04% |
+90,136
| New | +$3.87M |
|
489
Radian Group
RDN
$5.14B
| $4.3M | 0.04% |
263,044
+251,739
| +2,227% | +$4.59M |
|
490
Planet Fitness
PLNT
$4.23B
| $4.3M | 0.04% |
80,161
-942,204
| -92% | -$48.3M |
|
491
Iovance Biotherapeutics
IOVA
$2.23B
| $4.3M | 0.04% |
+485,506
| New | +$4.68M |
|
|
TVRD
492
Tvardi Therapeutics
TVRD
$23.5M
| $4.29M | 0.04% |
9,167
-3,342
| -27% | -$2.16M |
|
493
IPG Photonics
IPGP
$3.89B
| $4.28M | 0.04% |
37,765
+33,793
| +851% | +$4.49M |
|
494
Tenet Healthcare
THC
$20.1B
| $4.27M | 0.04% |
+249,152
| New | +$6.03M |
|
495
Targa Resources
TRGP
$60.4B
| $4.27M | 0.04% |
+118,522
| New | +$5.73M |
|
|
IIN
496
DELISTED
IntriCon Corporation
IIN
| $4.26M | 0.04% |
+161,585
| New | +$6.14M |
|
|
LOXO
497
DELISTED
Loxo Oncology, Inc
LOXO
| $4.24M | 0.04% |
+30,263
| New | +$4.59M |
|
|
LOGM
498
DELISTED
LogMein, Inc.
LOGM
| $4.23M | 0.04% |
51,846
-27,371
| -35% | -$2.31M |
|
499
Walt Disney
DIS
$165B
| $4.22M | 0.04% |
+38,460
| New | +$4.37M |
|
|
FSP
500
Franklin Street Properties
FSP
$44.8M
| $4.21M | 0.04% |
+675,113
| New | +$4.96M |
|
Similar funds
Marshall Wace's Q4 2018 Portfolio in Review
As of Q4 2018, Marshall Wace held 1,967 positions worth $9.8B, down 17% from $11.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Marshall Wace's Q4 2018 filing shows 854 new, 344 increased, 350 reduced and 392 closed positions. Its largest new stake was Mastercard: 339,646 shares worth $64.1M. The largest sale was McDonald's, an estimated $140M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
- Marshall Wace's largest Q4 2018 buy was Mastercard: 339,646 shares worth $64.1M.
- Marshall Wace added most to Alphabet (Google) Class A in Q4 2018, an estimated $97.9M increase.
- Marshall Wace's biggest Q4 2018 reduction was McDonald's, cutting an estimated $140M.
- Marshall Wace fully exited Aetna Inc in Q4 2018, selling an estimated $77M.
- Marshall Wace's ten largest holdings make up 15% of its $9.8B portfolio in Q4 2018.
- Marshall Wace opened 854 new positions and closed 392 in Q4 2018.
- Marshall Wace's portfolio value fell 17% quarter-over-quarter to $9.8B.
Based on Marshall Wace's 13F filing for Q4 2018, filed 14 Feb 2019.